Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 10, 2022
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, an increase of 4.6% from the previous quarter. The dividend...
Nov 2, 2022Ridgewood, NJ, November 2, 2022 – Valley-Mount Sinai Comprehensive Cancer Care is pleased to be the recipient of a $652,000 grant over three years from BD (Becton, Dickinson and Company), a...
Oct 26, 2022Conforms to Independently Audited International Standards for Information Security: ISO/IEC 27001:2022FRANKLIN LAKES, N.J. (Oct. 26, 2022) – BD (Becton, Dickinson and Company), a leading global medical technology company, today announced its enterprise-level Information Security Management...
Oct 18, 2022BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Magnolia Medical Technologies, Inc., today announced a co-exclusive commercial agreement aimed at...
-
Oct 17, 2022BD, Biocorp Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable DrugsCompanies to Explore Opportunities to Integrate Biocorp’s Injay® Technology with BD UltraSafePlus™ Passive Needle Guard to Help Biopharmaceutical Manufacturers Capture and Transmit Self-Administered Injection Data.
FRANKLIN LAKES, N.J. (October 17, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biocorp, a medical device and delivery systems...
-
Oct 13, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will report its fiscal 2022 fourth quarter and full year financial results on Thursday, November 10, 2022. A news release...
-
Oct 11, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Forbes' 2022 list of the World's Best Employers. "Empowering our teams to excel in...
Oct 3, 2022FRANKLIN LAKES, N.J. (Oct. 3, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Eric Borin has been named president of...
Sep 29, 2022Public-Private Partnership Supporting Diagnostic Testing in Vulnerable Communities has Provided $2.6 Million to U.S. Clinics Since 2017 to Help Improve Patient Outcomes and Health Equity FRANKLIN...
Sep 27, 2022Diagnostic Research Center Enables Students to Test and Develop Clinical Workflows to Help Shape Laboratory Performance and Patient Outcomes FRANKLIN LAKES, N.J., Sept. 27, 2022 /PRNewswire/ -- BD...